flupenthixol has been researched along with Schizophrenia in 201 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 104 (51.74) | 18.7374 |
| 1990's | 29 (14.43) | 18.2507 |
| 2000's | 37 (18.41) | 29.6817 |
| 2010's | 30 (14.93) | 24.3611 |
| 2020's | 1 (0.50) | 2.80 |
| Authors | Studies |
|---|---|
| Asmal, L; Chiliza, B; Emsley, R; Phahladira, L; Retief, M | 1 |
| Barbui, C; Bertolini, F; Bovo, C; Correll, CU; Del Giovane, C; Gastaldon, C; Nosé, M; Ogheri, F; Ostuzzi, G; Papola, D; Purgato, M; Tedeschi, F; Turrini, G | 1 |
| Asmal, L; Chiliza, B; du Plessis, S; Emsley, R; Kilian, S; Phahladira, L | 1 |
| Mehtälä, J; Taipale, H; Tanskanen, A; Tiihonen, J | 1 |
| Emsley, R; McGregor, N; O'Connell, KS; Thompson, N; van der Merwe, L; Warnich, L | 1 |
| Chen, CW; Huang, LC; Lin, SH; Yang, YK | 1 |
| Asmal, L; Chiliza, B; du Plessis, S; Emsley, R; Kilian, S; Luckhoff, HK; Phahladira, L; Scheffler, F | 1 |
| Li, FL; Liang, CS; Yang, FC; Yeh, TC | 1 |
| Asmal, L; Chiliza, B; du Plessis, S; Emsley, R; Kilian, S; Luckhoff, H; Phahladira, L; Scheffler, F | 1 |
| Adams, CE; Kwong, JS; Nyakyoma, K; Qi, F; Sinclair, DJ; Zhao, S | 1 |
| Bailey, L; Taylor, D | 1 |
| Frey, S; Juckel, G; Linder, R; Stargardt, T | 1 |
| Müller-Spahn, F | 1 |
| Bahmer, TJ; Eberle, MC; Ehlis, AC; Ernst, LH; Fallgatter, AJ; Metzger, FG; Pfuhlmann, B; Polak, T; Reif, A; Schneider, S; Walter, G | 1 |
| Engel, RR; Grohmann, R; Möller, HJ; Rüther, E; Stübner, S; van der Velden, JW | 1 |
| Asmal, L; Chiliza, B; Emsley, R; Esan, O; Gureje, O; Kidd, M; Ojagbemi, A; Oosthuizen, P | 1 |
| Adams, CE; David, A; Mahapatra, J; Quraishi, SN; Sampson, S | 1 |
| Dold, M; Engel, RR; Leucht, S; Tardy, M | 1 |
| Asmal, L; Chiliza, B; Emsley, R; Erasmus, R; Kidd, M; Malhotra, A; Oosthuizen, P; van Niekerk, E | 1 |
| Asmal, L; Chiliza, B; Emsley, R; Kilian, S; Phahladira, L | 1 |
| Asmal, L; Chiliza, B; Emsley, R; Kidd, M; Killian, S; Olivier, MR; Oosthuizen, PP; Schoeman, R | 1 |
| Emsley, R; Esan, O; Gureje, O; Ojagbemi, A | 1 |
| Asmal, L; Carr, J; Chiliza, B; du Plessis, S; Emsley, R; Kahn, RS; Kidd, M; Malhotra, AK; Vink, M | 1 |
| Chang, WH; Chen, KC; Chen, PS; Chi, MH; Hsiao, CY; Hui Lee, I; Lee, LT; Yang, YK; Yu, HY | 1 |
| Asmal, L; Carr, J; Chiliza, B; du Plessis, S; Emsley, R; Kidd, M; Vink, M | 1 |
| Cordes, J; Gründer, G; Heinze, M; Mühlbauer, B; Rüther, E; Schulz, C; Timm, J | 1 |
| Asmal, L; Chiliza, B; Drögemöller, BI; Emsley, RA; Ovenden, ES; van der Merwe, L; Warnich, L | 1 |
| Asmal, L; Carr, J; Chiliza, B; Dazzan, P; Emsley, R; Kidd, M; Kilian, S; Ojagbemi, A; Phahladira, L; Riaan Olivier, M; Scheffler, F | 1 |
| Glaser, T; Landen, H; Messer, T; Schmauss, M | 1 |
| Gericke, CA; Juckel, G; Mavrogiorgou, P; Stargardt, T | 1 |
| Lam, D; Patten, SB; Pringsheim, T; Tano, DS | 1 |
| Adams, CE; Shen, X; Xia, J | 1 |
| Ananjit, S; Badiah, Y; Bulgiba, A; Habil, MH; Hairi, NN; Haslina, MY; Hatim, A; Mahmud, B; Ramli, MA; Said, MA; Sapini, Y; Shah, M; Zafidah, W | 1 |
| Andrade, C | 1 |
| Benkert, O; Müller, MJ; Wetzel, H | 1 |
| Anghelescu, I; Benkert, O; Ewald-Gründer, S; Gründer, G; Hiemke, C; Hillert, A; Schlösser, R | 1 |
| Müller, P; Nerenz, H; Schaefer, E | 1 |
| Becker, D; Grinberg, Y; Mester, R; Weizman, A | 1 |
| Beneke, M; Dvorak, A; Glaser, T; Hertling, I; Lesch, OM; Mast, O; Philipp, M; Ramskogler, K; Saletu-Zyhlarz, G; Walter, H | 1 |
| Bellgrove, MA; Bradshaw, JL; Vance, A | 1 |
| Aichmüller, C; Beneke, M; Glaser, T; Hornung-Knobel, S; Soyka, M; v Bardeleben, U; Wegner, U | 1 |
| Chanpattana, W; Kramer, BA | 1 |
| Dose, M; Glaser, T; Lesch, OM; Philipp, M; Schmauss, M | 1 |
| Eerdekens, E; Eerdekens, M; Jacko, M; Turner, M | 1 |
| Brunnauer, A; Geiger, E; Laux, G; Möller, HJ | 1 |
| Kühn, KU; Landen, H; Quednow, BB; Riedel, M; Thiel, M | 1 |
| Bäumer, D; Ebert, D; Tebartz van Elst, L; Trimble, MR | 1 |
| Diehl, A; Dittmann, RW; Gattaz, WF; Geuppert, MS; Hubrich, P; Linde, I; Maras, A; Schmitt, A | 1 |
| Broll, K; Hess, L; Ibach, B; Perfahl, M; Pfeiff, L; Putzhammer, A | 1 |
| Kovács, G | 1 |
| Bäuml, J; Davis, JM; Engel, RR; Leucht, S | 1 |
| Clement, M; de Moore, GM | 1 |
| Bares, R; Bartels, M; Beneke, M; Glaser, T; Machulla, HJ; Noda, S; Reimold, M; Schaefer, JE; Solbach, C; Wormstall, H | 1 |
| Dunn, MJ; Killcross, S | 1 |
| Kissling, W; Lesch, OM; Philipp, M; Ruhrmann, S; Schmauss, M; Seemann, U | 1 |
| Gutwinski, S; Koller, M; Müller, P | 1 |
| Dembler, T; Gallinat, J; Heinz, A; Juckel, G; Kahnt, T; Kienast, T; Knutson, B; Koslowski, M; Schlagenhauf, F; Wrase, J | 1 |
| Chiang, HL; Liu, CC; Wu, SY | 1 |
| Dencker, SJ; Lepp, M; Malm, U | 3 |
| Blake, IM; Braddock, LE | 1 |
| Coufal, J; Novotný, M | 1 |
| Crow, TJ | 1 |
| Johnson, DA; Ludlow, JM; Pasterski, G; Street, K; Taylor, RD | 1 |
| Berkowitz, R; Eberlein-Fries, R; Kuipers, L; Leff, J; Sturgeon, D | 1 |
| Hansen, V; Jorgensen, A; Mackie, M; McCreadie, RG; Menzies, C; Wiles, DH | 1 |
| Ranta, J; Wistedt, B | 1 |
| Bourne, RC; Crow, TJ; Ferrier, IN; Frith, CD; Gamble, SJ; Johnstone, EC; Owens, DG | 1 |
| Jørgensen, A; Saikia, JK | 1 |
| Palmstierna, T; Wistedt, B | 1 |
| Pöldinger, W; Sieberns, S | 1 |
| Bridges, PK | 1 |
| Cross, AJ; Crow, TJ; Owen, F | 1 |
| Andersen, J; Bjørndal, N; Dencker, SJ; Jørgensen, A; Lundin, L; Malm, U | 1 |
| King, DJ; McDevitt, DG; Salem, SA | 1 |
| Jørgensen, A; Wiles, D; Wistedt, B | 1 |
| Parent, M; Toussaint, C | 2 |
| Eccleston, D; Fairbairn, AF; Hassanyeh, F; Hui, SM; Robinson, AJ; Rowell, FJ | 1 |
| Bloxham, CA; Cross, AJ; Ferrier, IN | 1 |
| Merson, I | 1 |
| Dencker, SJ; Frankenberg, K; Hansen, V; Malm, U | 1 |
| Jrgensen, A; Overø, KF | 1 |
| Dencker, SJ; Jørgensen, A; Malm, U; Overø, KF | 1 |
| Vichaiya, V | 1 |
| Johnson, DA | 3 |
| Wistedt, B | 1 |
| Cross, AJ; Crow, TJ; Johnstone, EC; Owen, F; Owens, DG; Waddington, JL | 1 |
| Bourne, RC; Crow, TJ; Fadhli, AA; Johnstone, EC; Owen, F | 1 |
| Barnes, TR; Bridges, PK | 1 |
| Thorburn, R | 1 |
| Gerlach, J | 1 |
| Sand, P; Soyka, M | 1 |
| Beneke, M; Fritze, J; Rasmus, W; Rød, IS | 1 |
| Vohra, SB | 1 |
| Chang, WH; Chen, H; Chen, TY; Chien, CP; Hu, WH; Hwu, HG; Lin, HN; Lin, SK; Lin, WL; Lung, FW | 1 |
| Gerlach, J; Larsen, EB | 1 |
| Levander, S; Tuninger, E | 1 |
| Gerlach, J; Lublin, H; Peacock, L; Solgaard, T | 1 |
| Budde, G; Greger, J; Haug, HJ; Jakobitsch, A; Osterheide, M; Pach, J; Sprenger, R; Tegeler, J | 1 |
| Wilkins, JN | 1 |
| Chen, AC; Gurling, HM; McDonald, B; Moss, SJ | 1 |
| Franken-Hiep, K; Horn, R; Osterheider, M | 1 |
| Curti, D; Das Gupta, F; Ferrier, IN; Jones, S; Marchbanks, RM; Taylor, C; Whatley, SA | 1 |
| Collins, ED; Coomaraswammy, S; Evans, SM; Kleber, HD; Levin, FR; Regent, N | 1 |
| Finkbeiner, T; Glaser, T; Haug, J; Osterheider, M; Pach, J; Tegeler, J | 1 |
| Anghelescu, I; Benkert, O; Gründer, G; Hiemke, C; Hillert, A; Lange, K; Schlösser, R; Wetzel, H | 1 |
| Berk, M; Pantanowitz, L | 1 |
| Buppanharun, W; Chakrabhand, ML; Chanpattana, W; Kongsakon, R; Techakasem, P | 1 |
| Chakrabhand, ML; Chanpattana, W; Choovanichvong, S; Kitaroonchai, W; Prasertsuk, Y | 1 |
| Buppanharun, W; Chakrabhand, ML; Chanpattana, W; Kirdcharoen, N; Kitaroonchai, W; Kongsakon, R; Sackeim, HA; Techakasem, P; Tuntirungsee, Y | 1 |
| Gruber, O; Northoff, G; Pflug, B | 1 |
| David, A; Quraishi, S | 1 |
| Möller, HJ | 1 |
| Kühn, KU; Maier, W; Meyer, K | 1 |
| Chanpattana, W | 1 |
| Chagkutip, J; Govitrapong, P; Srikiatkhachorn, A; Turakitwanakan, W | 1 |
| Chen, AC; Gurling, H | 1 |
| Anetseder, M; Kress, W; Müller, CR; Pedrosa Gil, F; Schneider, C; Schneider, M | 1 |
| Chakrabhand, ML; Chanpattana, W | 1 |
| Haasen, C; Krausz, M; Naber, D; Nika, E; Yagdiran, O | 1 |
| Gründig, E; Weiss, J | 1 |
| Crow, TJ; Johnstone, EC | 1 |
| Crow, TJ; Johnstone, EC; Longden, AJ; Owen, F | 1 |
| Carney, MW; Crow, TJ; Frith, CD; Johnstone, EC; Price, JS | 1 |
| Meltzer, HY | 1 |
| Baker, HF; Crow, TJ; Johnstone, EC; Joseph, MH | 1 |
| Card, IR; Hamilton, M; Mahmoud, MR; Wallis, GG | 1 |
| Jøorgensen, A; Kirk, L; Stauning, JA | 1 |
| Bourne, RC; Cotes, PM; Crow, TJ; Ferrier, IN; Johnstone, EC; Owen, F; Robinson, JD | 1 |
| Zapletálek, M | 1 |
| Bartlett, W; Bourne, RC; Cotes, PM; Crow, TJ; Johnstone, EC | 1 |
| Arató, M; Erdós, A | 1 |
| Flanagan, WL; Jorgensen, A; McCreadie, RG; McKnight, J | 1 |
| Bannerjee, A; Ghosh, N; Pinto, R | 1 |
| Eufe, R; Wegener, G | 1 |
| Hirsch, SR; Knights, A; Okasha, MS; Salih, MA | 1 |
| Banning, B; Freeman, HL; Kelly, HB; Schiff, AA | 1 |
| Crow, TJ; Frith, CD; Johnstone, EC; Stevens, M | 1 |
| Breen, M; Johnson, DA | 1 |
| Freeman, H | 1 |
| Sieberns, S | 1 |
| Gibson, AC | 1 |
| Frith, CD; Gold, A; Johnstone, EC; Stevens, M | 1 |
| Angst, J; Margoses, N; Woggon, B | 1 |
| Floru, L; Heinrich, K; Wittek, F | 1 |
| Baudis, P; Dvoráková, M; Peterová, E; Vencovský, E | 1 |
| Cotes, PM; Crow, TJ; Johnstone, EC | 1 |
| Crow, TJ; Frith, C; Johnstone, EC | 1 |
| Carney, MW; Sheffield, BF | 1 |
| Johnson, DA; Malik, NA | 1 |
| Gerlach, J; Kramp, P; Kristjansen, P; Lauritsen, B; Lühdorf, K; Munkvad, I | 1 |
| Capstick, N | 1 |
| Haffmans, PJ; Hoencamp, E; Jansen, GS | 1 |
| Krska, J; Sampath, G; Shah, A; Soni, SD | 1 |
| Ferrier, IN; Marchbanks, RM; Perrett, CW; Whatley, SA | 1 |
| Fischer, S; Kissling, W; Kuss, HJ | 1 |
| Aaes-Jørgensen, T; Gerlach, J; Kistrup, K; Larsen, NE | 1 |
| Cole, JO; Gruber, AJ | 1 |
| Hawton, K; Reznek, L; Shepstone, B; Soper, N | 1 |
| Kong, DS; Yeo, SH | 2 |
| Crockett, GT; Grant, S; Greene, JG; Kershaw, PW; Livingston, MG; Mahmood, Z; McCreadie, RG; Todd, NA; Watt, JA; Wiles, D | 1 |
| Balant-Gorgia, AE; Eisele, R; Garrone, G | 1 |
| Ardern, M; Gelder, MG; Jambor, K; Kolakowska, T; Mandelbrote, BM; Reveley, MA; Williams, AO | 1 |
| Ardern, M; Kolakowska, T; Williams, AO | 1 |
| Knudsen, P | 1 |
| Ardern, M; Kolakowska, T; Reveley, MA; Williams, AO | 1 |
| Johnstone, EC | 1 |
| Crow, TJ; Johnson, AL; Johnstone, EC; MacMillan, JF | 1 |
| Erba, E; Neder, A; Priest, RG; Pugh, CR; Robinson, C; Steinert, J | 1 |
| Dinan, TG | 1 |
| Bartkó, G; Herczeg, I; Zádor, G | 1 |
| Classen, W; Laux, G | 1 |
| Goodall, E; Silverstone, T; Smith, G | 1 |
| Farde, L; Halldin, C; Sedvall, G; Stone-Elander, S | 1 |
| Beninger, RJ; Delva, NJ; Ehmann, TS | 1 |
| Cookson, IB | 1 |
| Hunter, L; Turbott, J; Villiger, J | 2 |
| Lipska, B; Nurowska, K; Szukalski, B; Welbel, L | 1 |
| Johnson, DA; Ludlow, JM; Street, K; Taylor, RD | 1 |
| Eberhard, G; Hellbom, E | 1 |
| Cook, PE; Dermer, SW; McGurk, T | 1 |
| Haider, I | 1 |
| Balant, LP; Balant-Gorgia, AE; Eisele, R; Genet, C | 1 |
| Aeschlimann, JM; Balant, LP; Balant-Gorgia, AE; Eisele, R; Garrone, G | 1 |
| Gunby, B | 1 |
| De Buck, RP | 1 |
| Holden, JM | 1 |
| De Schepper, PJ; Hansen, T; Vranckx, CH | 1 |
| Gottfries, CG; Green, L | 1 |
| Agrup-Andersson, L; Bengtsson, A; Erlandsson, K; Gottfries, CG; Witzell-Ostlund, G | 1 |
| Gottfries, CG | 1 |
| Trueman, HR; Valentine, MG | 1 |
14 review(s) available for flupenthixol and Schizophrenia
| Article | Year |
|---|---|
Maintenance Treatment With Long-Acting Injectable Antipsychotics for People With Nonaffective Psychoses: A Network Meta-Analysis.
Topics: Antipsychotic Agents; Aripiprazole; Clopenthixol; Delayed-Action Preparations; Flupenthixol; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Network Meta-Analysis; Olanzapine; Paliperidone Palmitate; Patient Acceptance of Health Care; Phenothiazines; Psychotic Disorders; Risperidone; Schizophrenia; Secondary Prevention | 2021 |
Electroconvulsive therapy for treatment-resistant schizophrenia.
Topics: Adult; Antipsychotic Agents; Brief Psychiatric Rating Scale; Electroconvulsive Therapy; Female; Flupenthixol; Humans; Male; Memory Disorders; Patient Readmission; Piperazines; Randomized Controlled Trials as Topic; Schizophrenia; Standard of Care; Thiazoles; Treatment Outcome | 2019 |
Estimating the optimal dose of flupentixol decanoate in the maintenance treatment of schizophrenia-a systematic review of the literature.
Topics: Adult; Antipsychotic Agents; Delayed-Action Preparations; Dopamine Antagonists; Dose-Response Relationship, Drug; Female; Flupenthixol; Humans; Male; Middle Aged; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2019 |
Current use of atypical antipsychotics.
Topics: Antipsychotic Agents; Autoreceptors; Brain; Dose-Response Relationship, Drug; Flupenthixol; Haloperidol; Humans; Medication Adherence; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Presynaptic; Risperidone; Schizophrenia; Schizophrenic Psychology; Synaptic Transmission; Treatment Outcome | 2002 |
Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders.
Topics: Antipsychotic Agents; Delayed-Action Preparations; Flupenthixol; Humans; Psychotic Disorders; Randomized Controlled Trials as Topic; Schizophrenia; Tranquilizing Agents | 2014 |
Flupenthixol versus low-potency first-generation antipsychotic drugs for schizophrenia.
Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Chlorpromazine; Flupenthixol; Humans; Randomized Controlled Trials as Topic; Schizophrenia; Xerostomia | 2014 |
Flupenthixol versus placebo for schizophrenia.
Topics: Adult; Antipsychotic Agents; Flupenthixol; Humans; Randomized Controlled Trials as Topic; Schizophrenia; Stereoisomerism | 2012 |
The biology of schizophrenia.
Topics: Amphetamines; Antipsychotic Agents; Brain; Dopamine; Flupenthixol; Humans; Memory Disorders; Orientation; Receptors, Dopamine; Schizophrenia; Stereoisomerism; Thioxanthenes; Tomography, X-Ray Computed; Virus Diseases | 1982 |
Depot neuroleptics in relapse prevention: advantages and disadvantages.
Topics: Adult; Antipsychotic Agents; Delayed-Action Preparations; Dystonia; Female; Flupenthixol; Humans; Male; Middle Aged; Patient Readmission; Recurrence; Schizophrenia; Treatment Refusal | 1995 |
Depot flupenthixol decanoate for schizophrenia or other similar psychotic disorders.
Topics: Antipsychotic Agents; Delayed-Action Preparations; Flupenthixol; Humans; Psychotic Disorders; Schizophrenia; Tranquilizing Agents | 2000 |
Amisulpride: a review of its efficacy in schizophrenia.
Topics: Acute Disease; Amisulpride; Antipsychotic Agents; Brief Psychiatric Rating Scale; Chronic Disease; Clinical Trials as Topic; Flupenthixol; Haloperidol; Humans; Risperidone; Schizophrenia; Sulpiride; Treatment Outcome | 2000 |
[Flupenthixol--a partial atypical neuroleptic?].
Topics: Animals; Antipsychotic Agents; Dopamine Antagonists; Flupenthixol; Humans; Receptors, Dopamine; Receptors, Serotonin; Schizophrenia | 2000 |
[Current status of neuroleptic long term treatment of schizophrenia].
Topics: Ambulatory Care; Antiparkinson Agents; Chronic Disease; Delayed-Action Preparations; Flupenthixol; Fluphenazine; Fluspirilene; Humans; Long-Term Care; Penfluridol; Placebos; Prognosis; Recurrence; Schizophrenia; Tranquilizing Agents | 1975 |
Antidepressant effects of flupenthixol.
Topics: Affect; Antidepressive Agents; Cocaine; Depressive Disorder; Flupenthixol; Humans; Schizophrenia; Substance-Related Disorders | 1991 |
65 trial(s) available for flupenthixol and Schizophrenia
| Article | Year |
|---|---|
Quetiapine and flupentixol differentially improve anterior cingulate cortex function in schizophrenia patients: an event-related potential study.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Chi-Square Distribution; Cognition; Dibenzothiazepines; Electroencephalography; Evoked Potentials; Female; Flupenthixol; Germany; Gyrus Cinguli; Humans; Male; Middle Aged; Prefrontal Cortex; Prospective Studies; Quality of Life; Quetiapine Fumarate; Reaction Time; Schizophrenia; Schizophrenic Psychology; Time Factors; Treatment Outcome; Young Adult | 2013 |
Combining depot antipsychotic with an assertive monitoring programme for treating first-episode schizophrenia in a resource-constrained setting.
Topics: Adult; Antipsychotic Agents; Community Mental Health Services; Delayed-Action Preparations; Developing Countries; Female; Flupenthixol; Humans; Male; Medication Adherence; Patient Acceptance of Health Care; Quality of Life; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2016 |
Changes in brain regions associated with food-intake regulation, body mass and metabolic profiles during acute antipsychotic treatment in first-episode schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Body Mass Index; Brain; Delayed-Action Preparations; Double-Blind Method; Eating; Female; Flupenthixol; Humans; Image Interpretation, Computer-Assisted; Injections, Intramuscular; Magnetic Resonance Imaging; Male; Middle Aged; Risperidone; Schizophrenia; South Africa; Young Adult | 2015 |
Dorsal striatal volumes in never-treated patients with first-episode schizophrenia before and during acute treatment.
Topics: Adult; Antipsychotic Agents; Caudate Nucleus; Double-Blind Method; Female; Flupenthixol; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Organ Size; Psychiatric Status Rating Scales; Psychotic Disorders; Putamen; Risperidone; Schizophrenia; Schizophrenic Psychology; Software; Treatment Outcome; Young Adult | 2015 |
Differential effects of high-dose amisulpride versus flupentixol on latent dimensions of depressive and negative symptomatology in acute schizophrenia: an evaluation using confirmatory factor analysis.
Topics: Adolescent; Adult; Affect; Aged; Amisulpride; Antipsychotic Agents; Double-Blind Method; Factor Analysis, Statistical; Female; Flupenthixol; Humans; Male; Middle Aged; Schizophrenia; Schizophrenic Psychology; Sulpiride | 2002 |
Long-term effects of the substituted benzamide derivative amisulpride on baseline and stimulated prolactin levels.
Topics: Adult; Amisulpride; Antipsychotic Agents; Drug Administration Schedule; Female; Flupenthixol; Humans; Male; Middle Aged; Prolactin; Schizophrenia; Sulpiride; Thyrotropin-Releasing Hormone; Time Factors | 2002 |
Flupenthixol versus risperidone: subjective quality of life as an important factor for compliance in chronic schizophrenic patients.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Attitude to Health; Double-Blind Method; Female; Flupenthixol; Humans; Male; Middle Aged; Patient Satisfaction; Psychiatric Status Rating Scales; Quality of Life; Risperidone; Schizophrenia; Schizophrenic Psychology; Surveys and Questionnaires; Treatment Outcome | 2003 |
Flupenthixol in relapse prevention in schizophrenics with comorbid alcoholism: results from an open clinical study.
Topics: Adult; Alcoholism; Antipsychotic Agents; Combined Modality Therapy; Comorbidity; Diagnosis, Dual (Psychiatry); Female; Flupenthixol; Germany; Humans; Injections, Intramuscular; Male; Middle Aged; Patient Dropouts; Schizophrenia; Schizophrenic Psychology; Switzerland; Treatment Outcome | 2003 |
[Comparative effectiveness of flupenthixol and risperidone on negative symptoms of schizophrenia].
Topics: Antipsychotic Agents; Chronic Disease; Depression; Double-Blind Method; Dyskinesia, Drug-Induced; Flupenthixol; Humans; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2003 |
Long-acting injectable risperidone: safety and efficacy in stable patients switched from conventional depot antipsychotics.
Topics: Adult; Antipsychotic Agents; Clopenthixol; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Flupenthixol; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Male; Middle Aged; Movement Disorders; Psychiatric Status Rating Scales; Risperidone; Schizophrenia | 2004 |
The impact of antipsychotics on psychomotor performance with regards to car driving skills.
Topics: Adolescent; Adult; Antipsychotic Agents; Automobile Driving; Clozapine; Female; Flupenthixol; Humans; Male; Middle Aged; Psychomotor Performance; Schizophrenia; Schizophrenic Psychology; Visual Perception | 2004 |
Olanzapine versus flupenthixol in the treatment of inpatients with schizophrenia: a randomized double-blind trial.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Brief Psychiatric Rating Scale; Case-Control Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Flupenthixol; Humans; Inpatients; Male; Olanzapine; Schizophrenia; Treatment Outcome | 2004 |
[Alterations of gait parameters under external cueing in schizophrenic patients: a switch study].
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dose-Response Relationship, Drug; Exercise Test; Female; Flupenthixol; Fluphenazine; Gait; Haloperidol; Humans; Male; Middle Aged; Muscle Rigidity; Olanzapine; Schizophrenia | 2004 |
Occupancy of dopamine D(1), D (2) and serotonin (2A) receptors in schizophrenic patients treated with flupentixol in comparison with risperidone and haloperidol.
Topics: Adult; Antipsychotic Agents; Corpus Striatum; Female; Flupenthixol; Frontal Lobe; Haloperidol; Humans; Male; Middle Aged; Positron-Emission Tomography; Radioligand Assay; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D1; Receptors, Dopamine D2; Risperidone; Schizophrenia; Schizophrenic Psychology | 2007 |
Efficacy of flupentixol and risperidone in chronic schizophrenia with predominantly negative symptoms.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Chronic Disease; Data Interpretation, Statistical; Depressive Disorder; Dyskinesia, Drug-Induced; Employment; Female; Flupenthixol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2007 |
Psychosocial relevance and benefit of neuroleptic maintenance: experience in the United Kingdom.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Attitude to Health; Clinical Trials as Topic; Delayed-Action Preparations; Family; Family Therapy; Female; Flupenthixol; Fluphenazine; Follow-Up Studies; Health Education; Humans; Interview, Psychological; Life Change Events; Male; Middle Aged; Outcome and Process Assessment, Health Care; Psychotherapy, Group; Recurrence; Schizophrenia; Schizophrenic Psychology; Stress, Psychological; United Kingdom | 1984 |
Comparative double-blind study of flupenthixol decanoate and fluphenazine decanoate in the treatment of patients relapsing in a schizophrenic symptomatology.
Topics: Adult; Aged; Chronic Disease; Clinical Trials as Topic; Depression; Double-Blind Method; Flupenthixol; Fluphenazine; Humans; Middle Aged; Random Allocation; Recurrence; Schizophrenia; Thioxanthenes; Time Factors | 1983 |
Adverse effects of anticholinergic medication on positive schizophrenic symptoms.
Topics: Adult; Dose-Response Relationship, Drug; Drug Therapy, Combination; Extrapyramidal Tracts; Female; Flupenthixol; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Procyclidine; Prolactin; Pyrrolidines; Schizophrenia; Schizophrenic Psychology; Thioxanthenes | 1983 |
Depressive symptoms in chronic schizophrenic patients after withdrawal of long-acting neuroleptics.
Topics: Adult; Depressive Disorder; Double-Blind Method; Female; Flupenthixol; Fluphenazine; Humans; Male; Psychiatric Status Rating Scales; Random Allocation; Recurrence; Schizophrenia; Schizophrenic Psychology; Substance Withdrawal Syndrome; Thioxanthenes; Tranquilizing Agents | 1983 |
A depot neuroleptic withdrawal study. Plasma concentration of fluphenazine and flupenthixol and relapse frequency.
Topics: Delayed-Action Preparations; Female; Flupenthixol; Fluphenazine; Humans; Male; Recurrence; Schizophrenia; Substance Withdrawal Syndrome; Thioxanthenes; Time Factors | 1982 |
Flupenthixol versus haloperidol in acute psychosis.
Topics: Acute Disease; Adolescent; Adult; Aged; Anxiety Disorders; Bipolar Disorder; Female; Flupenthixol; Haloperidol; Humans; Male; Middle Aged; Paranoid Disorders; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Thioxanthenes | 1983 |
Clinical trial of flupenthixol decanoate in chronic withdrawn schizophrenic patients.
Topics: Adult; Aged; Chronic Disease; Clinical Trials as Topic; Female; Flupenthixol; Humans; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Thioxanthenes | 1980 |
Studies of depressive symptoms in schizophrenia.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Flupenthixol; Fluphenazine; Humans; Longitudinal Studies; Male; Middle Aged; Nortriptyline; Orphenadrine; Schizophrenia; Schizophrenic Psychology | 1981 |
A depot neuroleptic withdrawal study. A controlled study of the clinical effects of the withdrawal of depot fluphenazine decanoate and depot flupenthixol decanoate in chronic schizophrenic patients.
Topics: Adult; Aged; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Female; Flupenthixol; Fluphenazine; Humans; Male; Middle Aged; Placebos; Recurrence; Schizophrenia; Substance Withdrawal Syndrome; Thioxanthenes | 1981 |
[Flupenthixol versus haloperidol in acute psychotic episodes].
Topics: Acute Disease; Adolescent; Adult; Aged; Bipolar Disorder; Double-Blind Method; Flupenthixol; Haloperidol; Humans; Middle Aged; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Thioxanthenes | 1982 |
Plasma homovanillic acid and treatment response in a large group of schizophrenic patients.
Topics: Adolescent; Adult; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Flupenthixol; Haloperidol; Homovanillic Acid; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1993 |
Clozapine versus typical antipsychotics. A retro- and prospective study of extrapyramidal side effects.
Topics: Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Clozapine; Female; Flupenthixol; Humans; Male; Middle Aged; Perphenazine; Prospective Studies; Schizophrenia | 1996 |
[Non-compliance and lack of indications for depot treatment as reasons for exclusion from adequate prevention of recurrence].
Topics: Double-Blind Method; Flupenthixol; Humans; Patient Selection; Psychiatric Status Rating Scales; Recurrence; Schizophrenia; Schizophrenic Psychology; Tranquilizing Agents; Treatment Outcome; Treatment Refusal | 1996 |
[Positive and negative symptoms in chronic schizophrenic patients under maintenance therapy with flupenthixol decanoate for a twelve month perioid].
Topics: Adult; Antipsychotic Agents; Chronic Disease; Female; Flupenthixol; Follow-Up Studies; Humans; Male; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1998 |
Neuroendocrine response to antipsychotics: effects of drug type and gender.
Topics: Adult; Amisulpride; Antipsychotic Agents; Double-Blind Method; Female; Flupenthixol; Human Growth Hormone; Humans; Male; Neurosecretory Systems; Prolactin; Schizophrenia; Schizophrenic Psychology; Sex Factors; Sulpiride; Thyrotropin | 1999 |
Short-term effect of combined ECT and neuroleptic therapy in treatment-resistant schizophrenia.
Topics: Acute Disease; Adult; Antipsychotic Agents; Combined Modality Therapy; Electroconvulsive Therapy; Female; Flupenthixol; Follow-Up Studies; Humans; Male; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 1999 |
Continuation ECT in treatment-resistant schizophrenia: a controlled study.
Topics: Adult; Antipsychotic Agents; Combined Modality Therapy; Electroconvulsive Therapy; Female; Flupenthixol; Humans; Male; Middle Aged; Prospective Studies; Recurrence; Schizophrenia; Single-Blind Method | 1999 |
Maintenance ECT in treatment-resistant schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Brief Psychiatric Rating Scale; Combined Modality Therapy; Drug Resistance; Electroconvulsive Therapy; Female; Flupenthixol; Humans; Long-Term Care; Male; Prognosis; Prospective Studies; Schizophrenia; Treatment Failure; Treatment Outcome | 2000 |
Stereochemical specificity in the antipsychotic effects of flupenthixol in man [proceedings].
Topics: Antipsychotic Agents; Clinical Trials as Topic; Flupenthixol; Humans; Schizophrenia; Stereoisomerism; Thioxanthenes | 1977 |
Mechanism of the antipsychotic effect in the treatment of acute schizophrenia.
Topics: Acute Disease; Adolescent; Adult; Chlorpromazine; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Female; Flupenthixol; Humans; Isomerism; Male; Placebos; Receptors, Dopamine; Research Design; Schizophrenia; Thioxanthenes | 1978 |
3-Methoxy-4-hydroxyphenylglycol excretion in acutely schizophrenic patients during a controlled clinical trial of the isomers of flupenthixol.
Topics: Adult; Clinical Trials as Topic; Female; Flupenthixol; Glycols; Humans; Isomerism; Male; Methoxyhydroxyphenylglycol; Middle Aged; Schizophrenia; Thioxanthenes | 1979 |
A comparative trial of the decanoates of flupenthixol and fluphenazine.
Topics: Adult; Aged; Chronic Disease; Clinical Trials as Topic; Decanoates; Female; Flupenthixol; Fluphenazine; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Thioxanthenes | 1979 |
Neuroendocrine changes in acute schizophrenia as a function of clinical state and neuroleptic medication.
Topics: Acute Disease; Chlorpromazine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Flupenthixol; Follicle Stimulating Hormone; Growth Hormone; Humans; Luteinizing Hormone; Orphenadrine; Prolactin; Receptors, Dopamine; Schizophrenia; Testosterone; Thioxanthenes | 1978 |
[Experience with depot neuroleptics].
Topics: Adolescent; Adult; Clinical Trials as Topic; Delayed-Action Preparations; Drug Evaluation; Drug Therapy, Combination; Female; Flupenthixol; Fluphenazine; Humans; Male; Middle Aged; Recurrence; Schizophrenia; Thioxanthenes | 1979 |
High dose flupenthixol decanoate in chronic schizophrenia.
Topics: Adult; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Female; Flupenthixol; Humans; Middle Aged; Random Allocation; Schizophrenia; Thioxanthenes | 1979 |
A double-blind comparison of flupenthixol decanoate and fluphenazine decanoate in the treatment of chronic schizophrenia.
Topics: Chronic Disease; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Flupenthixol; Fluphenazine; Humans; Psychiatric Status Rating Scales; Random Allocation; Schizophrenia; Thioxanthenes | 1979 |
[Double-blind comparison of 2 depot neuroleptics (perphenazine enanthate and flupentixol decanoate) in chronic schizophrenia (author's transl)].
Topics: Adult; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Flupenthixol; Humans; Middle Aged; Perphenazine; Psychiatric Status Rating Scales; Schizophrenia; Thioxanthenes | 1979 |
Depressive and extrapyramidal symptoms and clinical effects: a trial of fluphenazine versus flupenthixol in maintenance of schizophrenic out-patients.
Topics: Adolescent; Adult; Aged; Basal Ganglia Diseases; Clinical Trials as Topic; Depression; Flupenthixol; Fluphenazine; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Social Adjustment; Thioxanthenes | 1979 |
Skin conductance responsivity during acute episodes of schizophrenia as a predictor of symptomatic improvement.
Topics: Acute Disease; Flupenthixol; Galvanic Skin Response; Habituation, Psychophysiologic; Humans; Schizophrenia; Stereoisomerism; Structure-Activity Relationship; Thioxanthenes | 1979 |
The outcome of severe acute schizophrenic illnesses after one year.
Topics: Acute Disease; Affect; Cognition; Drug Evaluation; Flupenthixol; Follow-Up Studies; Humans; Isomerism; Prognosis; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Social Isolation; Thioxanthenes; Verbal Behavior | 1979 |
The problem of post-psychotic schizophrenic depressions and their pharmacological induction. Long-term studies with fluspirilene and penfluridol and single-blind trial with fluphenazine-decanoate and flupenthixol-decanoate.
Topics: Adult; Antidepressive Agents; Clinical Trials as Topic; Depression; Female; Flupenthixol; Fluphenazine; Fluspirilene; Humans; Long-Term Care; Male; Penfluridol; Personality Inventory; Piperidines; Schizophrenia; Spiro Compounds; Thioxanthenes | 1975 |
Serum prolactin as an index of dopamine receptor blockade in acute schizophrenia [proceedings].
Topics: Acute Disease; Flupenthixol; Humans; Prolactin; Receptors, Dopamine; Schizophrenia | 1977 |
The clinical effects of the isomers of flupenthixol--the consequences of dopamine receptor blockade in acute schizophrenia [proceedings].
Topics: Flupenthixol; Humans; Receptors, Dopamine; Schizophrenia; Stereoisomerism; Thioxanthenes | 1977 |
A double-blind comparison of fluphenazine decanoate and flupenthixol decanoate in the treatment of acute schizophrenia.
Topics: Acute Disease; Chlorpromazine; Clinical Trials as Topic; Drug Evaluation; Flupenthixol; Fluphenazine; Humans; Placebos; Schizophrenia; Time Factors | 1975 |
Peroral and parenteral administration of long-acting neuroleptics: a double-blind study of penfluridol compared to flupenthixol decanoate in the treatment of schizophrenia.
Topics: Administration, Oral; Adolescent; Adult; Aged; Clinical Trials as Topic; Delayed-Action Preparations; Drug Evaluation; Flupenthixol; Humans; Injections; Male; Middle Aged; Penfluridol; Piperidines; Placebos; Schizophrenia; Thioxanthenes | 1975 |
The Scottish first episode schizophrenia study. VIII. Five-year follow-up: clinical and psychosocial findings. The Scottish Schizophrenia Research Group.
Topics: Activities of Daily Living; Administration, Oral; Adult; Caregivers; Combined Modality Therapy; Double-Blind Method; Female; Flupenthixol; Follow-Up Studies; Hospitalization; Humans; Male; Marital Status; Pimozide; Psychiatric Status Rating Scales; Psychometrics; Rehabilitation, Vocational; Schizophrenia; Schizophrenic Psychology; Scotland; Social Adjustment | 1992 |
Antidepressant effects of flupenthixol.
Topics: Affect; Antidepressive Agents; Cocaine; Depressive Disorder; Flupenthixol; Humans; Schizophrenia; Substance-Related Disorders | 1991 |
An open clinical trial with the long-acting neuroleptics flupenthixol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia.
Topics: Clinical Trials as Topic; Female; Flupenthixol; Fluphenazine; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Thioxanthenes; Tranquilizing Agents | 1989 |
The Scottish first episode schizophrenia study. VII. Two-year follow-up. Scottish Schizophrenia Research Group.
Topics: Clinical Trials as Topic; Double-Blind Method; Family; Flupenthixol; Follow-Up Studies; Humans; Pimozide; Psychiatric Status Rating Scales; Recurrence; Schizophrenia; Schizophrenic Psychology; Scotland; Social Adjustment; Thioxanthenes | 1989 |
A randomised controlled trial of prophylactic neuroleptic treatment.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Chlorpromazine; Clinical Trials as Topic; Female; Flupenthixol; Follow-Up Studies; Haloperidol; Humans; Male; Middle Aged; Pimozide; Random Allocation; Recurrence; Schizophrenia; Time Factors; Trifluoperazine | 1986 |
A comparative trial of depot pipothiazine.
Topics: Adult; Antipsychotic Agents; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Female; Flupenthixol; Humans; Male; Middle Aged; Phenothiazines; Psychiatric Status Rating Scales; Random Allocation; Schizophrenia; Thiazines; Thioxanthenes; Time Factors; Tranquilizing Agents | 1986 |
The Scottish First Episode Schizophrenia Study. II. Treatment: pimozide versus flupenthixol. The Scottish Schizophrenia Research Group.
Topics: Adolescent; Adult; Aged; Behavior; Female; Flupenthixol; Humans; Male; Middle Aged; Parkinson Disease, Secondary; Pimozide; Prolactin; Schizophrenia; Schizophrenic Psychology; Thioxanthenes | 1987 |
Sensorimotor and cognitive performance of schizophrenic inpatients treated with haloperidol, flupenthixol, or clozapine.
Topics: Adult; Antipsychotic Agents; Cognition Disorders; Female; Flupenthixol; Haloperidol; Humans; Male; Psychomotor Performance; Schizophrenia; Schizophrenic Psychology | 1988 |
Flupenthixol in chronic schizophrenic inpatients: a controlled comparison with haloperidol.
Topics: Adult; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Female; Flupenthixol; Haloperidol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Random Allocation; Schizophrenia; Thioxanthenes | 1987 |
The effects of a 50% reduction of cis(z)-flupenthixol decanoate in chronic schizophrenic patients maintained on a high dose regime.
Topics: Adult; Chronic Disease; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Female; Flupenthixol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Thioxanthenes | 1987 |
Double-blind comparison of half-dose and standard-dose flupenthixol decanoate in the maintenance treatment of stabilised out-patients with schizophrenia.
Topics: Adult; Aged; Ambulatory Care; Dose-Response Relationship, Drug; Double-Blind Method; Female; Flupenthixol; Humans; Male; Middle Aged; Random Allocation; Schizophrenia; Thioxanthenes; Tranquilizing Agents | 1987 |
Haloperidol decanoate and flupenthixol decanoate in schizophrenia. A long-term double-blind cross-over comparison.
Topics: Adult; Double-Blind Method; Female; Flupenthixol; Haloperidol; Humans; Male; Middle Aged; Schizophrenia; Thioxanthenes | 1986 |
Flupenthixol decanoate (fluanxol depot) in the treatment of chronic schizophrenic patients.
Topics: Adolescent; Adult; Aged; Chronic Disease; Clinical Trials as Topic; Delayed-Action Preparations; Female; Flupenthixol; Humans; Length of Stay; Male; Middle Aged; Schizophrenia; Thioxanthenes; Tranquilizing Agents | 1985 |
Flupenthixol decanoate - controlled investigation concerning dosage -.
Topics: Clinical Trials as Topic; Female; Flupenthixol; Humans; Paranoid Disorders; Placebos; Schizophrenia; Thioxanthenes; Time Factors | 1974 |
Flupentixol and flupentixol decanoate, with special reference to their antipsychotic effect.
Topics: Adolescent; Adult; Aged; Body Weight; Clinical Trials as Topic; Decanoates; Flupenthixol; Humans; Injections; Mental Processes; Middle Aged; Psychotic Disorders; Schizophrenia; Thioxanthenes; Trifluoperazine | 1974 |
123 other study(ies) available for flupenthixol and Schizophrenia
| Article | Year |
|---|---|
Prolactin, flupenthixol decanoate and first episode schizophrenia - clinical and laboratory correlates.
Topics: Adolescent; Adult; Age Factors; Female; Flupenthixol; Humans; Hyperprolactinemia; Male; Propafenone; Schizophrenia; Sex Factors; Tranquilizing Agents; Treatment Outcome; Young Adult | 2019 |
Brain volume changes over the first year of treatment in schizophrenia: relationships to antipsychotic treatment.
Topics: Adult; Antipsychotic Agents; Cerebral Cortex; Delayed-Action Preparations; Female; Flupenthixol; Gray Matter; Humans; Magnetic Resonance Imaging; Male; Psychotic Disorders; Schizophrenia; Treatment Outcome; White Matter; Young Adult | 2017 |
Comparative Effectiveness of Antipsychotic Drugs for Rehospitalization in Schizophrenia-A Nationwide Study With 20-Year Follow-up.
Topics: Adult; Aged; Antipsychotic Agents; Clozapine; Female; Finland; Flupenthixol; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Olanzapine; Paliperidone Palmitate; Patient Readmission; Perphenazine; Prevalence; Schizophrenia; Secondary Prevention; Young Adult | 2018 |
Modification of the association between antipsychotic treatment response and childhood adversity by MMP9 gene variants in a first-episode schizophrenia cohort.
Topics: Adolescent; Adult; Adult Survivors of Child Adverse Events; Antipsychotic Agents; Female; Flupenthixol; Gene-Environment Interaction; Haplotypes; Humans; Male; Matrix Metalloproteinase 9; Polymorphism, Genetic; Schizophrenia; Treatment Outcome; Young Adult | 2018 |
Transcranial direct current stimulation (tDCS) improved psychomotor slowness and decreased catatonia in a patient with schizophrenia: Case report.
Topics: Adult; Amantadine; Antipsychotic Agents; Bupropion; Catatonia; Female; Flupenthixol; Humans; Psychomotor Performance; Schizophrenia; Schizophrenic Psychology; Stereotyped Behavior; Transcranial Direct Current Stimulation | 2018 |
Changes in insight over the first 24 months of treatment in schizophrenia spectrum disorders.
Topics: Adolescent; Adult; Antipsychotic Agents; Cognition; Female; Flupenthixol; Health Personnel; Humans; Longitudinal Studies; Male; Psychiatric Status Rating Scales; Psychotic Disorders; Quality of Life; Schizophrenia; Schizophrenic Psychology; Time Factors; Treatment Outcome; Young Adult | 2019 |
Combined typical and atypical long-acting injectable antipsychotics in treatment-resistant schizophrenia: Two cases.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Drug Therapy, Combination; Female; Flupenthixol; Humans; Male; Middle Aged; Paliperidone Palmitate; Schizophrenia; Treatment Outcome | 2019 |
Weight gain and metabolic change as predictors of symptom improvement in first-episode schizophrenia spectrum disorder patients treated over 12 months.
Topics: Adult; Body Mass Index; Dopamine Antagonists; Female; Flupenthixol; Humans; Longitudinal Studies; Male; Outcome Assessment, Health Care; Schizophrenia; Severity of Illness Index; Weight Gain; Young Adult | 2019 |
Cost-effectiveness of long-acting injectable risperidone versus flupentixol decanoate in the treatment of schizophrenia: a Markov model parameterized using administrative data.
Topics: Adult; Antipsychotic Agents; Cost-Benefit Analysis; Delayed-Action Preparations; Female; Flupenthixol; Hospitalization; Humans; Male; Markov Chains; Middle Aged; Models, Econometric; Risperidone; Schizophrenia | 2014 |
Flupentixol use and adverse reactions in comparison with other common first- and second-generation antipsychotics: data from the AMSP study.
Topics: Antipsychotic Agents; Female; Flupenthixol; Humans; Male; Observation; Product Surveillance, Postmarketing; Psychiatric Status Rating Scales; Schizophrenia; Time Factors | 2014 |
Changes in body mass and metabolic profiles in patients with first-episode schizophrenia treated for 12 months with a first-generation antipsychotic.
Topics: Adult; Antipsychotic Agents; Biomarkers; Blood Glucose; Body Mass Index; Cholesterol; Cohort Studies; Female; Flupenthixol; Humans; Male; Metabolic Syndrome; Metabolome; Schizophrenia; South Africa; Triglycerides; Weight Gain | 2015 |
Rate and predictors of non-response to first-line antipsychotic treatment in first-episode schizophrenia.
Topics: Adolescent; Adult; Age Factors; Antipsychotic Agents; Body Mass Index; Cohort Studies; Female; Flupenthixol; Humans; Longitudinal Studies; Male; Psychotic Disorders; Quality of Life; Schizophrenia; Treatment Outcome; Young Adult | 2015 |
Cognitive performance during the first year of treatment in first-episode schizophrenia: a case-control study.
Topics: Adolescent; Adult; Antipsychotic Agents; Attention; Case-Control Studies; Cognition; Factor Analysis, Statistical; Female; Flupenthixol; Humans; Longitudinal Studies; Male; Memory, Short-Term; Problem Solving; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Verbal Learning; Young Adult | 2015 |
Motor sequencing abnormalities are the trait marking neurological soft signs of schizophrenia.
Topics: Adult; Antipsychotic Agents; Black People; Female; Flupenthixol; Humans; Male; Neurologic Examination; Psychiatric Status Rating Scales; Schizophrenia; Young Adult | 2015 |
A comparison of the effectiveness of risperidone, haloperidol and flupentixol long-acting injections in patients with schizophrenia--A nationwide study.
Topics: Adult; Antipsychotic Agents; Drug Delivery Systems; Female; Flupenthixol; Haloperidol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Statistics, Nonparametric; Treatment Outcome | 2015 |
Patient-oriented randomisation: A new trial design applied in the Neuroleptic Strategy Study.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clinical Studies as Topic; Flupenthixol; Haloperidol; Humans; Olanzapine; Patient-Centered Care; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Research Design; Schizophrenia | 2016 |
Fine-mapping of antipsychotic response genome-wide association studies reveals novel regulatory mechanisms.
Topics: Adolescent; Adult; Antipsychotic Agents; Chromosome Mapping; Cohort Studies; Female; Flupenthixol; Genetic Variation; Genome-Wide Association Study; Humans; Male; Polymorphism, Single Nucleotide; Schizophrenia; South Africa; Treatment Outcome; Young Adult | 2017 |
Neurological soft signs in first-episode schizophrenia: State- and trait-related relationships to psychopathology, cognition and antipsychotic medication effects.
Topics: Antipsychotic Agents; Cognition; Female; Flupenthixol; Humans; Interview, Psychological; Linear Models; Longitudinal Studies; Male; Memory, Short-Term; Motor Activity; Neurologic Examination; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Treatment Outcome; Young Adult | 2017 |
Long-term treatment with flupentixol results of a post-marketing surveillance study.
Topics: Adult; Antipsychotic Agents; Female; Flupenthixol; Follow-Up Studies; Humans; Male; Product Surveillance, Postmarketing; Quality of Life; Schizophrenia; Schizophrenic Psychology; Time Factors; Treatment Outcome | 2009 |
Effectiveness and costs of flupentixol compared to other first- and second-generation antipsychotics in the treatment of schizophrenia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Cohort Studies; Cost-Benefit Analysis; Drug Costs; Female; Flupenthixol; Follow-Up Studies; Health Care Costs; Hospitalization; Humans; Male; Middle Aged; Regression Analysis; Retrospective Studies; Schizophrenia; Young Adult | 2011 |
The pharmacoepidemiology of antipsychotics for adults with schizophrenia in Canada, 2005 to 2009.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Canada; Chlorpromazine; Clopenthixol; Clozapine; Female; Flupenthixol; Humans; Loxapine; Male; Olanzapine; Pharmacoepidemiology; Schizophrenia | 2011 |
Metabolic syndrome and antipsychotic monotherapy treatment among schizophrenia patients in Malaysia.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Clozapine; Cross-Sectional Studies; Female; Flupenthixol; Humans; Malaysia; Male; Metabolic Syndrome; Middle Aged; Piperazines; Quinolones; Schizophrenia; Trifluoperazine; Waist Circumference; Young Adult | 2013 |
Flupenthixol decanoate and injection site abscesses in an obese patient.
Topics: Abscess; Adult; Antipsychotic Agents; Buttocks; Delayed-Action Preparations; Flupenthixol; Humans; Injections, Intramuscular; Injections, Subcutaneous; Male; Obesity; Schizophrenia | 2002 |
[The risk of rehospitalisation during therapy with atypical and typical neuroleptics--a contribution to differential indication].
Topics: Administration, Oral; Adult; Ambulatory Care; Antipsychotic Agents; Delayed-Action Preparations; Female; Flupenthixol; Germany; Humans; Male; Middle Aged; Patient Readmission; Psychiatric Status Rating Scales; Recurrence; Retrospective Studies; Risk; Schizophrenia; Treatment Outcome | 2002 |
Association between flupenthixol treatment and emergence of manic symptoms.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Diagnostic and Statistical Manual of Mental Disorders; Female; Flupenthixol; Humans; Male; Middle Aged; Retrospective Studies; Schizophrenia | 2002 |
Local-global processing in early-onset schizophrenia: evidence for an impairment in shifting the spatial scale of attention.
Topics: Adolescent; Affect; Antipsychotic Agents; Attention; Benzodiazepines; Clopenthixol; Diazepam; Female; Flupenthixol; Frontal Lobe; Humans; Male; Olanzapine; Parietal Lobe; Perceptual Disorders; Pirenzepine; Reaction Time; Risperidone; Schizophrenia; Space Perception; Time Factors | 2003 |
Acute and maintenance ECT with flupenthixol in refractory schizophrenia: sustained improvements in psychopathology, quality of life, and social outcomes.
Topics: Acute Disease; Adult; Antipsychotic Agents; Brief Psychiatric Rating Scale; Combined Modality Therapy; Electroconvulsive Therapy; Female; Flupenthixol; Humans; Male; Quality of Life; Schizophrenia; Severity of Illness Index; Social Adjustment; Treatment Outcome | 2003 |
[Quality of life and therapeutic result in outpatients with schizophrenia under flupenthixol treatment].
Topics: Adult; Antipsychotic Agents; Delayed-Action Preparations; Female; Flupenthixol; Humans; Injections, Intravenous; Male; Middle Aged; Outpatients; Psychiatric Status Rating Scales; Quality of Life; Schizophrenia; Surveys and Questionnaires; Treatment Outcome | 2004 |
Chronic antidopaminergic medication might affect amygdala structure in patients with schizophrenia.
Topics: Amygdala; Antipsychotic Agents; Brain; Clopenthixol; Dose-Response Relationship, Drug; Epilepsy, Temporal Lobe; Factor Analysis, Statistical; Flupenthixol; Haloperidol; Hippocampus; Humans; Psychotic Disorders; Risperidone; Schizophrenia; Trifluoperazine | 2004 |
[Prescription of psychotropic drugs for schizophrenic outpatients in Hungary].
Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Clozapine; Cross-Sectional Studies; Drug Prescriptions; Female; Flupenthixol; Humans; Hungary; Male; Middle Aged; Olanzapine; Outpatients; Risperidone; Schizophrenia; Serotonin Antagonists; Surveys and Questionnaires | 2005 |
Is the superior efficacy of new generation antipsychotics an artifact of LOCF?
Topics: Amisulpride; Artifacts; Benzodiazepines; Bias; Flupenthixol; Haloperidol; Humans; Olanzapine; Patient Dropouts; Psychiatric Status Rating Scales; Psychotropic Drugs; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenic Psychology; Sulpiride; Treatment Outcome | 2007 |
Self-cannibalism: an unusual case of self-mutilation.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cannibalism; Flupenthixol; Humans; Male; Olanzapine; Schizophrenia; Self-Injurious Behavior; Treatment Refusal | 2006 |
Medial prefrontal cortex infusion of alpha-flupenthixol attenuates systemic d-amphetamine-induced disruption of conditional discrimination performance in rats.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Central Nervous System Stimulants; Conditioning, Operant; Dextroamphetamine; Discrimination Learning; Disease Models, Animal; Dopamine Antagonists; Dose-Response Relationship, Drug; Flupenthixol; Male; Microinjections; Prefrontal Cortex; Rats; Receptors, Dopamine; Schizophrenia | 2007 |
[Intervals between hospitalisations in schizophrenia patients under antipsychotics in depot-form versus oral second generation antipsychotics].
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Clozapine; Delayed-Action Preparations; Female; Flupenthixol; Hospitals, Psychiatric; Humans; Male; Middle Aged; Patient Readmission; Retrospective Studies; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2007 |
Reward system activation in schizophrenic patients switched from typical neuroleptics to olanzapine.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Dopamine D2 Receptor Antagonists; Female; Flupenthixol; Fluphenazine; Haloperidol; Humans; Magnetic Resonance Imaging; Male; Motivation; Neostriatum; Nucleus Accumbens; Olanzapine; Oxygen; Psychomotor Performance; Reaction Time; Receptors, Dopamine D2; Reward; Schizophrenia; Schizophrenic Psychology | 2008 |
Applying long-acting injectable antipsychotics in first-episode schizophrenia to achieve first remission.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Delayed-Action Preparations; Female; Flupenthixol; Humans; Injections, Intramuscular; Olanzapine; Patient Compliance; Risperidone; Schizophrenia; Secondary Prevention; Treatment Outcome | 2008 |
Do schizophrenics well adapted in the community need neuroleptics? A depot neuroleptic withdrawal study.
Topics: Ambulatory Care; Antipsychotic Agents; Chronic Disease; Clopenthixol; Delayed-Action Preparations; Flupenthixol; Follow-Up Studies; Humans; Psychiatric Status Rating Scales; Recurrence; Schizophrenia; Social Adjustment; Substance Withdrawal Syndrome; Time Factors | 1980 |
Neuroendocrine tests during treatment with neuroleptic drugs. II. The TRH test.
Topics: Adult; Aged; Antipsychotic Agents; Delayed-Action Preparations; Female; Flupenthixol; Fluphenazine; Growth Hormone; Haloperidol; Humans; Male; Middle Aged; Pituitary Function Tests; Prolactin; Schizophrenia; Stimulation, Chemical; Thyrotropin-Releasing Hormone | 1981 |
Fluphenazine and flupenthixol decanoate in psychiatric outpatients practice.
Topics: Adult; Antipsychotic Agents; Female; Flupenthixol; Fluphenazine; Humans; Male; Middle Aged; Schizophrenia; Thioxanthenes | 1981 |
The discontinuance of maintenance neuroleptic therapy in chronic schizophrenic patients: drug and social consequences.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Drug Administration Schedule; Female; Flupenthixol; Fluphenazine; Humans; Male; Psychiatric Status Rating Scales; Recurrence; Schizophrenia; Schizophrenic Psychology; Social Adjustment; Thioxanthenes | 1983 |
Within-individual variation in steady state plasma levels of different neuroleptics and prolactin.
Topics: Administration, Oral; Adult; Aged; Antipsychotic Agents; Flupenthixol; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Kinetics; Male; Middle Aged; Pimozide; Prolactin; Schizophrenia | 1984 |
Steady-state serum concentrations after cis (Z)-flupentixol decanoate in viscoleo.
Topics: Adult; Aged; Delayed-Action Preparations; Flupenthixol; Humans; Middle Aged; Schizophrenia; Thioxanthenes; Time Factors | 1983 |
Depression-inducing and antidepressive effects of neuroleptics. Experiences with flupenthixol and flupenthixol decanoate.
Topics: Anxiety Disorders; Bipolar Disorder; Depressive Disorder; Double-Blind Method; Flupenthixol; Humans; Schizophrenia; Thioxanthenes | 1983 |
Disturbed behavior induced by high-dose antipsychotic drugs.
Topics: Adult; Behavior; Female; Flupenthixol; Humans; Pregnancy; Pregnancy Complications; Schizophrenia; Thioxanthenes | 1981 |
3H-Flupenthixol binding in post-mortem brains of schizophrenics: evidence for a selective increase in dopamine D2 receptors.
Topics: Binding, Competitive; Brain; Caudate Nucleus; Flupenthixol; Humans; Kinetics; Receptors, Dopamine; Schizophrenia; Thioxanthenes | 1981 |
Serum concentrations of cis(Z)-flupentixol and prolactin in chronic schizophrenic patients treated with flupentixol and cis(Z)-flupentixol decanoate.
Topics: Administration, Oral; Adult; Chronic Disease; Female; Flupenthixol; Half-Life; Humans; Injections, Intravenous; Male; Middle Aged; Prolactin; Schizophrenia; Thioxanthenes | 1982 |
Induction of microsomal enzyme activity by flupenthixol in chronic schizophrenics.
Topics: Adult; Aged; Antipyrine; Chronic Disease; Enzyme Induction; Flupenthixol; Half-Life; Humans; Microsomes, Liver; Middle Aged; Schizophrenia; Thioxanthenes | 1982 |
Serum concentration of depot neuroleptics in tardive dyskinesia.
Topics: Dyskinesia, Drug-Induced; Female; Flupenthixol; Fluphenazine; Humans; Male; Middle Aged; Schizophrenia; Thioxanthenes | 1983 |
Dopamine D1 receptors in human parathyroid gland: in vitro and in vivo studies.
Topics: Adult; Apomorphine; Flupenthixol; Humans; Male; Metoclopramide; Parathyroid Glands; Parathyroid Hormone; Prolactin; Receptors, Dopamine; Schizophrenia; Thioxanthenes | 1983 |
Clinical forum. 5 - schizophrenia: never to be happy.
Topics: Flupenthixol; Humans; Male; Pimozide; Schizophrenia; Thioxanthenes | 1982 |
Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. I. A one year double-blind study of clopenthixol decanoate and flupenthixol palmitate.
Topics: Adult; Aged; Ambulatory Care; Chronic Disease; Clopenthixol; Delayed-Action Preparations; Double-Blind Method; Drug Evaluation; Female; Flupenthixol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Thioxanthenes; Time Factors | 1980 |
Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. II. Factor analysis of the CPRS sub-scale for schizophrenia.
Topics: Adult; Aged; Ambulatory Care; Chronic Disease; Clopenthixol; Delayed-Action Preparations; Drug Evaluation; Factor Analysis, Statistical; Female; Flupenthixol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Thioxanthenes; Time Factors | 1980 |
Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. III. Serum levels.
Topics: Ambulatory Care; Clopenthixol; Delayed-Action Preparations; Flupenthixol; Half-Life; Humans; Injections, Intramuscular; Schizophrenia; Thioxanthenes; Time Factors | 1980 |
Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. IV. Serum levels and clinical outcome.
Topics: Ambulatory Care; Clopenthixol; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Flupenthixol; Humans; Prognosis; Psychiatric Status Rating Scales; Schizophrenia; Thioxanthenes | 1980 |
Abnormal involuntary movements in schizophrenia: are they related to the disease process or its treatment? Are they associated with changes in dopamine receptors?
Topics: Adult; Aged; Brain; Dyskinesia, Drug-Induced; Female; Flupenthixol; Humans; Male; Middle Aged; Mouth Diseases; Receptors, Dopamine; Schizophrenia; Species Specificity; Spiperone | 1982 |
Platelet monoamine oxidase activity in acute schizophrenia: relationship to symptomatology and neuroleptic medication.
Topics: Acute Disease; Blood Platelets; Chlorpromazine; Female; Flupenthixol; Humans; Male; Monoamine Oxidase; Schizophrenia; Sex Factors; Thioxanthenes | 1981 |
Disturbed behavior induced by high-dose antipsychotic drugs.
Topics: Adult; Aggression; Drug Administration Schedule; Female; Flupenthixol; Fluphenazine; Humans; Male; Schizophrenia; Thioxanthenes | 1980 |
Dystonia and neuroleptic medication.
Topics: Antipsychotic Agents; Dystonia; Flupenthixol; Humans; Laryngeal Diseases; Long-Term Care; Schizophrenia; Voice Disorders | 1995 |
Successful treatment with flupenthixol decanoate of a patient with both schizophrenia and alcoholism.
Topics: Adult; Alcoholism; Flupenthixol; Humans; Male; Schizophrenia; Schizophrenic Psychology; Tranquilizing Agents | 1995 |
Correct titration of non-drugs and some other methodological issues.
Topics: Administration, Oral; Amitriptyline; Anxiety Disorders; Benperidol; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Doxepin; Drug Administration Schedule; Flupenthixol; Fluspirilene; Haloperidol; Humans; Imipramine; Injections, Intramuscular; Promethazine; Psychotropic Drugs; Pyrimidines; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenic Psychology; Single-Blind Method | 1994 |
Convulsions after enflurane in a schizophrenic patient receiving neuroleptics.
Topics: Adult; Anesthesia, Inhalation; Chlorpromazine; Drug Synergism; Enflurane; Epilepsy, Tonic-Clonic; Flupenthixol; Humans; Male; Schizophrenia; Seizures | 1994 |
Subjective experience of treatment, side-effects, mental state and quality of life in chronic schizophrenic out-patients treated with depot neuroleptics.
Topics: Adult; Aged; Antipsychotic Agents; Chronic Disease; Clopenthixol; Delayed-Action Preparations; Dyskinesia, Drug-Induced; Female; Flupenthixol; Humans; Male; Middle Aged; Neurologic Examination; Perphenazine; Psychiatric Status Rating Scales; Quality of Life; Schizophrenia; Sick Role | 1996 |
Large variations of plasma levels during maintenance treatment with depot neuroleptics.
Topics: Adult; Aged; Antipsychotic Agents; Delayed-Action Preparations; Drug Monitoring; Female; Flupenthixol; Follow-Up Studies; Haloperidol; Humans; Injections, Intramuscular; Long-Term Care; Male; Middle Aged; Neurologic Examination; Perphenazine; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1996 |
Pharmacotherapy of schizophrenia patients with comorbid substance abuse.
Topics: Alcoholism; Antipsychotic Agents; Cocaine; Flupenthixol; Humans; Imipramine; Marijuana Abuse; Opioid-Related Disorders; Schizophrenia; Self Medication; Substance-Related Disorders; Tobacco Use Disorder | 1997 |
Gene expression studies of mRNAs encoding the NMDA receptor subunits NMDAR1, NMDAR2A, NMDAR2B, NMDAR2C, and NMDAR2D following long-term treatment with cis-and trans-flupenthixol as a model for understanding the mode of action of schizophrenia drug treatme
Topics: Administration, Oral; Animals; Flupenthixol; Gene Expression Regulation; Male; Models, Biological; Molecular Sequence Data; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; RNA, Messenger; Schizophrenia | 1998 |
[Total illness costs of schizophrenia and monetary evaluation of prevention of recurrence exemplified by a standard depot neuroleptic (flupenthixol decanoate)].
Topics: Adult; Aged; Ambulatory Care; Cost Savings; Dopamine Antagonists; Female; Flupenthixol; Germany; Humans; Male; Middle Aged; Patient Readmission; Recurrence; Schizophrenia; Schizophrenic Psychology; Social Security | 1998 |
Superoxide, neuroleptics and the ubiquinone and cytochrome b5 reductases in brain and lymphocytes from normals and schizophrenic patients.
Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Brain Chemistry; Cytochrome Reductases; Cytochrome-B(5) Reductase; Female; Flupenthixol; Gene Expression Regulation, Enzymologic; Humans; In Situ Hybridization; Lipid Peroxidation; Lymphocytes; Male; Middle Aged; Mitochondria; NAD; NAD(P)H Dehydrogenase (Quinone); Oligonucleotide Probes; Oxidative Stress; RNA, Messenger; Schizophrenia; Superoxides; Ubiquinone | 1998 |
Flupenthixol treatment for cocaine abusers with schizophrenia: a pilot study.
Topics: Adult; Antipsychotic Agents; Cocaine-Related Disorders; Diagnosis, Dual (Psychiatry); Female; Flupenthixol; Humans; Male; Middle Aged; Neurologic Examination; Pilot Projects; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Substance Abuse Detection; Treatment Outcome | 1998 |
Auto-amputation of the tongue associated with flupenthixol induced extrapyramidal symptoms.
Topics: Adult; Amputation, Traumatic; Flupenthixol; Humans; Male; Schizophrenia; Tongue | 1999 |
Effects of twice- versus thrice-weekly electroconvulsive therapy in schizophrenia.
Topics: Adult; Antipsychotic Agents; Chi-Square Distribution; Drug Resistance; Electroconvulsive Therapy; Female; Flupenthixol; Humans; Male; Middle Aged; Retrospective Studies; Schizophrenia; Survival Analysis; Time Factors; Treatment Outcome | 1999 |
[Effect of activation tasks on acute neuroleptic-induced akathisia].
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Arousal; Attention; Benperidol; Diagnosis, Differential; Female; Flupenthixol; Haloperidol; Humans; Male; Middle Aged; Motor Skills; Neurologic Examination; Problem Solving; Schizophrenia | 2000 |
Platelet 5-HT(2A) receptors in schizophrenic patients with and without neuroleptic treatment.
Topics: Adult; Antipsychotic Agents; Blood Platelets; Case-Control Studies; Dopamine Antagonists; Dose-Response Relationship, Drug; Female; Flupenthixol; Humans; Ketanserin; Male; Phenothiazines; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Risperidone; Schizophrenia; Serotonin Antagonists; Spiperone | 2000 |
Gene expression in schizophrenia.
Topics: Animals; Antipsychotic Agents; Blotting, Western; Brain; Flupenthixol; Functional Laterality; Gene Expression Regulation; Humans; Nucleic Acid Hybridization; Oligonucleotide Probes; Rats; Receptors, Dopamine D2; Receptors, N-Methyl-D-Aspartate; Research Design; RNA, Messenger; Schizophrenia | 2001 |
Intolerance to neuroleptics and susceptibility for malignant hyperthermia in a patient with proximal myotonic myopathy (PROMM) and schizophrenia.
Topics: Adult; Antipsychotic Agents; Biopsy; Event-Related Potentials, P300; Flupenthixol; Humans; Male; Malignant Hyperthermia; Muscle, Skeletal; Myotonic Disorders; Schizophrenia | 2002 |
Combined ECT and neuroleptic therapy in treatment-refractory schizophrenia: prediction of outcome.
Topics: Adult; Combined Modality Therapy; Electroconvulsive Therapy; Female; Flupenthixol; Humans; Male; Mental Status Schedule; Prospective Studies; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2001 |
Switching to amisulpride due to hepatic complications.
Topics: Adult; Amisulpride; Antipsychotic Agents; Chemical and Drug Induced Liver Injury; Flupenthixol; Haloperidol; Humans; Male; Perazine; Schizophrenia; Sulpiride | 2002 |
[The influence of neuroleptic drugs on urinary excretion of non-protein nitrogen (author's transl)].
Topics: Amino Acids; Clopenthixol; Clozapine; Creatinine; Delayed-Action Preparations; Flupenthixol; Fluphenazine; Humans; Hydrogen-Ion Concentration; Ion Exchange Resins; Nitrogen; Procyclidine; Schizophrenia; Thioridazine; Tranquilizing Agents; Urea | 1976 |
Dopaminergic mechanisms in schizophrenia: the antipsychotic effect and the disease process.
Topics: Antipsychotic Agents; Brain; Dopamine; Flupenthixol; Humans; In Vitro Techniques; Isomerism; Receptors, Dopamine; Schizophrenia | 1978 |
Mechanisms of antipsychotic effect in treatment of acute schizophrenia.
Topics: Acute Disease; Flupenthixol; Humans; Schizophrenia; Thioxanthenes; Time Factors | 1978 |
Comparison of serum levels after intramuscular injections of 2% and 10% cis(Z)-flupentixol decanoate in Viscoleo to schizophrenic patients.
Topics: Adult; Aged; Delayed-Action Preparations; Female; Flupenthixol; Humans; Injections, Intramuscular; Middle Aged; Pharmaceutical Vehicles; Schizophrenia; Thioxanthenes; Time Factors | 1979 |
Blood levels of flupenthixol in patients with acute and chronic schizophrenia.
Topics: Acute Disease; Animals; Chronic Disease; Cross Reactions; Flupenthixol; Humans; In Vitro Techniques; Male; Radioimmunoassay; Radioligand Assay; Rats; Schizophrenia; Thioxanthenes; Time Factors | 1979 |
[The effects of thioridazine, flupenthixol and haloperidol on serum catalase activity in schizophrenia].
Topics: Adult; Catalase; Female; Flupenthixol; Haloperidol; Humans; Male; Middle Aged; Schizophrenia; Statistics as Topic; Thioridazine; Thioxanthenes | 1977 |
Clinical and social comparison of fluphenazine decanoate and flupenthixol decanoate in the community maintenance therapy of schizophrenia.
Topics: Adolescent; Adult; Chronic Disease; Community Mental Health Services; Female; Flupenthixol; Fluphenazine; Humans; Long-Term Care; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Social Adjustment; Thioxanthenes | 1977 |
Weight changes with depot neuroleptic maintenance therapy.
Topics: Body Weight; Decanoates; Delayed-Action Preparations; Flupenthixol; Fluphenazine; Humans; Prospective Studies; Schizophrenia; Time Factors | 1979 |
Pimozide as a neuroleptic.
Topics: Delusions; Dyskinesia, Drug-Induced; Flupenthixol; Fluphenazine; Humans; Pimozide; Schizophrenia | 1979 |
Further observations on the duration of depot neuroleptic maintenance therapy in schizophrenia.
Topics: Delayed-Action Preparations; Flupenthixol; Fluphenazine; Humans; Recurrence; Schizophrenia; Thioxanthenes | 1979 |
[Studies on the long acting neuroleptic agent flupenthixol decanoate--a review (author's transl)].
Topics: Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Interactions; Dyskinesia, Drug-Induced; Flupenthixol; Humans; Psychotic Disorders; Schizophrenia; Thioxanthenes | 1978 |
Depot injections and tardive dyskinesia.
Topics: Chorea; Delayed-Action Preparations; Dyskinesia, Drug-Induced; Female; Flupenthixol; Fluphenazine; Humans; Injections; Male; Middle Aged; Prospective Studies; Schizophrenia; Thioxanthenes | 1978 |
[Clinical experiences with depot neuroleptics].
Topics: Delayed-Action Preparations; Depressive Disorder, Major; Female; Flupenthixol; Fluphenazine; Humans; Male; Psychotic Disorders; Schizophrenia; Thioxanthenes | 1975 |
Comparison of antipsychotic depot injections in the maintenance treatment of schizophrenia.
Topics: Adolescent; Adult; Aged; Basal Ganglia Diseases; Delayed-Action Preparations; Depression; Female; Flupenthixol; Fluphenazine; Humans; Injections, Intramuscular; Male; Middle Aged; Mortality; Patient Compliance; Patient Readmission; Schizophrenia; Thioxanthenes; Time Factors | 1976 |
Depressive reactions in the course of clomipramine therapy used in the treatment of obsessional conditions.
Topics: Adult; Aged; Amitriptyline; Clomipramine; Depression; Dibenzazepines; Female; Flupenthixol; Humans; Male; Obsessive-Compulsive Disorder; Schizophrenia | 1975 |
Lowest effective dose of depot neuroleptics.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Flupenthixol; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology | 1992 |
Rationalizing neuroleptic polypharmacy in chronic schizophrenics: effects of changing to a single depot preparation.
Topics: Administration, Oral; Antipsychotic Agents; Chronic Disease; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Flupenthixol; Fluphenazine; Humans; Injections, Intramuscular; Male; Middle Aged; Neurologic Examination; Psychiatric Status Rating Scales; Recurrence; Schizophrenia; Schizophrenic Psychology | 1992 |
Changes in relative levels of specific brain mRNA species associated with schizophrenia and depression.
Topics: Aged; Cerebral Cortex; Death; Depressive Disorder; Electrophoresis, Gel, Two-Dimensional; Flupenthixol; Humans; Molecular Weight; Nerve Tissue Proteins; Poly A; Postmortem Changes; Protein Biosynthesis; Reference Values; Reticulocytes; RNA; RNA, Messenger; Schizophrenia | 1992 |
Schizophrenic patients treated with high dose phenothiazine or thioxanthene become deficient in polyunsaturated fatty acids in their thrombocytes.
Topics: Adult; Blood Platelets; Fatty Acids; Fatty Acids, Unsaturated; Female; Flupenthixol; Humans; Male; Middle Aged; Oxidation-Reduction; Perazine; Phenothiazines; Schizophrenia | 1992 |
Perphenazine decanoate and cis(z)-flupentixol decanoate in maintenance treatment of schizophrenic outpatients. Serum levels at the minimum effective dose.
Topics: Adult; Chronic Disease; Dose-Response Relationship, Drug; Female; Flupenthixol; Humans; Male; Middle Aged; Outpatients; Perphenazine; Psychiatric Status Rating Scales; Schizophrenia | 1991 |
Single-photon emission computerised tomography (SPECT) in schizophrenia.
Topics: Adult; Brain; Cerebrovascular Circulation; Chlorpromazine; Female; Flupenthixol; Humans; Schizophrenia; Temporal Lobe; Tomography, Emission-Computed, Single-Photon | 1990 |
[Quantitative approach to treatment with incisive neuroleptics by therapeutic monitoring].
Topics: Adult; Antipsychotic Agents; Drug Interactions; Female; Flupenthixol; Haloperidol; Humans; Kinetics; Male; Middle Aged; Psychotic Disorders; Schizophrenia | 1985 |
Schizophrenia with good and poor outcome. I: Early clinical features, response to neuroleptics and signs of organic dysfunction.
Topics: Adult; Antiparkinson Agents; Antipsychotic Agents; Brain; Chlorpromazine; Cognition Disorders; Female; Flupenthixol; Fluphenazine; Humans; Male; Middle Aged; Prognosis; Prolactin; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Tomography, X-Ray Computed | 1985 |
Tardive dyskinesia and current dose of neuroleptic drugs.
Topics: Adult; Antipsychotic Agents; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Flupenthixol; Fluphenazine; Humans; Middle Aged; Psychotic Disorders; Schizophrenia | 1985 |
Chemotherapy with neuroleptics. Clinical and pharmacokinetic aspects with a particular view to depot preparations.
Topics: Administration, Oral; Antipsychotic Agents; Clopenthixol; Delayed-Action Preparations; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Flupenthixol; Fluphenazine; Haloperidol; Humans; Kinetics; Long-Term Care; Patient Compliance; Perphenazine; Schizophrenia; Schizophrenic Psychology; Thiazines | 1985 |
Tardive dyskinesia in schizophrenics under 60 years of age.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Flupenthixol; Fluphenazine; Humans; Male; Prognosis; Schizophrenia | 1986 |
Acute schizophrenia.
Topics: Acute Disease; Antipsychotic Agents; Flupenthixol; Humans; Kinetics; Prolactin; Recurrence; Schizophrenia | 1985 |
Neuroleptic effects on platelet aggregation: a study in normal volunteers and schizophrenics.
Topics: Adolescent; Adult; Antipsychotic Agents; Chlorpromazine; Delayed-Action Preparations; Flupenthixol; Fluphenazine; Haloperidol; Humans; Male; Platelet Aggregation; Procyclidine; Schizophrenia; Sulpiride; Trifluoperazine | 1987 |
Clinical symptomatology and drug compliance in schizophrenic patients.
Topics: Adult; Antipsychotic Agents; Delayed-Action Preparations; Female; Flupenthixol; Fluphenazine; Fluspirilene; Humans; Male; Middle Aged; Patient Compliance; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1988 |
Prevalence of obesity in patients receiving depot antipsychotics.
Topics: Adult; Antipsychotic Agents; Delayed-Action Preparations; Female; Flupenthixol; Fluphenazine; Humans; Male; Obesity; Schizophrenia; Social Class | 1988 |
PET analysis of human dopamine receptor subtypes using 11C-SCH 23390 and 11C-raclopride.
Topics: Adult; Benzazepines; Brain; Carbon Radioisotopes; Flupenthixol; Humans; Male; Middle Aged; Raclopride; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides; Schizophrenia; Sulpiride | 1987 |
The significance of depression in the prediction of relapse in chronic schizophrenia.
Topics: Adult; Depressive Disorder; Female; Flupenthixol; Fluphenazine; Humans; Male; Middle Aged; Recurrence; Risk Factors; Schizophrenia; Schizophrenic Psychology; Time Factors | 1988 |
The Scottish First Episode Schizophrenia Study V. One-year follow-up. The Scottish Schizophrenia Research Group.
Topics: Adaptation, Psychological; Cognition; Family; Flupenthixol; Follow-Up Studies; Hospitalization; Humans; Interpersonal Relations; Pimozide; Prognosis; Schizophrenia; Schizophrenic Psychology; Scotland; Social Adjustment; Thioxanthenes; Tranquilizing Agents | 1988 |
Depot neuroleptic medication and serum levels by radioreceptor assay: prolactin concentration, electrocardiogram abnormalities and six-month outcome.
Topics: Adult; Delayed-Action Preparations; Dose-Response Relationship, Drug; Electrocardiography; Female; Flupenthixol; Fluphenazine; Heart; Humans; Male; Middle Aged; Prolactin; Radioligand Assay; Schizophrenia; Thioxanthenes | 1987 |
Radioreceptor assay in checking serum concentration in long-term treatment with cis(z)-flupenthixol decanoate.
Topics: Adult; Female; Flupenthixol; Humans; Injections; Male; Middle Aged; Radioligand Assay; Schizophrenia; Thioxanthenes | 1987 |
Schizophrenic relapse after drug withdrawal is predictable.
Topics: Adult; Aged; Clopenthixol; Female; Flupenthixol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Psychometrics; Recurrence; Schizophrenia; Schizophrenic Psychology; Substance Withdrawal Syndrome; Thioxanthenes | 1986 |
Fatal overdose with amantadine.
Topics: Adult; Amantadine; Drug Therapy, Combination; Flupenthixol; Humans; Male; Schizophrenia; Schizophrenic Psychology; Suicide | 1986 |
Flupenthixol decanoate and fluphenazine decanoate in chronic schizophrenia.
Topics: Adult; Chronic Disease; Female; Flupenthixol; Fluphenazine; Humans; Male; Middle Aged; Schizophrenia; Thioxanthenes | 1985 |
Neuroleptic serum levels measured by radioreceptor assay in patients receiving intramuscular depot neuroleptics. Some preliminary findings.
Topics: Adult; Delayed-Action Preparations; Female; Flupenthixol; Fluphenazine; Humans; Male; Middle Aged; Schizophrenia; Thioxanthenes | 1985 |
Comparative determination of flupentixol in plasma by gas chromatography and radioimmunoassay in schizophrenic patients.
Topics: Administration, Oral; Adolescent; Adult; Chromatography, Gas; Delayed-Action Preparations; Female; Flupenthixol; Humans; Male; Middle Aged; Radioimmunoassay; Schizophrenia; Thioxanthenes | 1985 |
Plasma flupentixol concentrations and clinical response in acute schizophrenia.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Chromatography, Gas; Female; Flupenthixol; Humans; Male; Middle Aged; Schizophrenia; Thioxanthenes | 1985 |
Clinical physiognomy of flupentixol.
Topics: Anxiety Disorders; Depression; Female; Flupenthixol; Humans; Mental Disorders; Schizophrenia; Thioxanthenes | 1974 |
Antiautistic effect of flupentixol.
Topics: Adult; Autistic Disorder; Child; Defense Mechanisms; Depression; Flupenthixol; Humans; Schizophrenia; Thioxanthenes | 1974 |
Clinical and electoencephalographical studies of the thioxanthenes.
Topics: Depression; Electroencephalography; Flupenthixol; Humans; Schizophrenia; Sleep; Thiothixene; Thioxanthenes; Trifluoperazine | 1974 |
Pharmacokinetics of flupentixol decanoate.
Topics: Decanoates; Flupenthixol; Humans; Male; Schizophrenia; Therapeutic Equivalency; Thioxanthenes | 1974 |
Flupenthixol decanoate--in treatment of out-patients.
Topics: Ambulatory Care; Female; Flupenthixol; Follow-Up Studies; Humans; Length of Stay; Male; Outpatient Clinics, Hospital; Paranoid Disorders; Psychotic Disorders; Recurrence; Schizophrenia; Thioxanthenes | 1974 |
Flupenthixol decanoate in schizophrenia.
Topics: Adult; Aged; Delayed-Action Preparations; Esters; Female; Flupenthixol; Humans; Male; Middle Aged; Piperazines; Schizophrenia; Thioxanthenes; Tranquilizing Agents | 1974 |